Revvity Inc (STU:PKN)
€ 114.55 0.5 (0.44%) Market Cap: 14.29 Bil Enterprise Value: 16.21 Bil PE Ratio: 61.12 PB Ratio: 1.96 GF Score: 78/100

PerkinElmer Inc at Citi Healthcare Conference (Virtual) Transcript

Feb 24, 2022 / 01:45PM GMT
Release Date Price: €143.05 (-8.48%)
Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

Great. Thank you all for joining us at the Citi Healthcare Conference here. I'm Patrick Donnelly, the tools and diagnostics analyst at Citi. Excited to have Prahlad Singh, CEO of PerkinElmer with us today. We have about 40 minutes. If anyone has any questions, they want me to ask, feel free to e-mail them over, and I will try to get them in.

Questions & Answers

Patrick Bernard Donnelly
Citigroup Inc., Research Division - Senior Analyst

And Prahlad, maybe to open up kind of at a high level, you guys have done obviously a bunch of acquisitions, I think, 9 acquisitions in the last year or so. Can you just talk about the strategy behind these deals? And then more broadly, how you're shaping the company for the future since you became CEO a couple of years ago?

Prahlad R. Singh
PerkinElmer, Inc. - CEO, President & Director

Thank you, Patrick. Good morning, good afternoon, good evening, everyone. When I came to PerkinElmer about 7

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot